mdm2 mdm2 mouse double minute 2 homolog (mdm2) also known as e3 ubiquitin-protein ligase mdm2 is a protein that in humans is encoded by the mdm2 gene. mdm2 is an important negative regulator of the p53 tumor suppressor. mdm2 protein functions both as an e3 ubiquitin ligase that recognizes the n-terminal trans-activation domain (tad) of the p53 tumor suppressor and as an inhibitor of p53 transcriptional activation. mdm2available structurespdbortholog search: pdbe rcsb list of pdb id codes1rv1, 1t4e, 1t4f, 1ycr, 1z1m, 2axi, 2c6a, 2c6b, 2fop, 2gv2, 2hdp, 2lzg, 2m86, 2mps, 2ruh, 2vje, 2vjf, 3eqs, 3g03, 3iux, 3iwy, 3jzk, 3jzr, 3jzs, 3lbk, 3lbl, 3lnj, 3lnz, 3mqs, 3tj2, 3tpx, 3tu1, 3v3b, 3vbg, 3vzv, 3w69, 4dij, 4ere, 4erf, 4hbm, 4hfz, 4hg7, 4jv7, 4jv9, 4jve, 4jvr, 4jwr, 4mdn, 4mdq, 4oas, 4oba, 4occ, 4ode, 4odf, 4ogn, 4ogt, 4ogv, 4oq3, 4qo4, 4qoc, 4umn, 4wt2, 4xxb, 4zyc, 4zyf, 4zyi, 4ue1, 4ud7, 5afg, 5hmi, 5hmk, 5hmh, 5c5aidentifiersaliasesmdm2, actfs, hdmx, hdm2, mdm2 proto-oncogene, lskbexternal idsomim: 164785 mgi: 96952 homologene: 1793 genecards: mdm2 gene location (human)chr.chromosome 12 (human)band12q15start68,808,177 bpend68,845,544 bpgene location (mouse)chr.chromosome 10 (mouse)band10 d2|10 66.32 cmstart117,524,780 bpend117,546,663 bprna expression patternbgeehumanmouse (ortholog)top expressed inachilles tendonright uterine tubesural nervestromal cell of endometriumright lobe of liverganglionic eminencebody of pancreasright lungleft adrenal glandthymustop expressed inseminiferous tubulespermatocytespermatidaortic valvesecondary oocyteascending aortathymusganglionic eminenceextensor digitorum longus musclesuperior frontal gyrusmore reference expression databiogpsmore reference expression datagene ontologymolecular function scaffold protein binding protein binding enzyme binding metal ion binding identical protein binding ubiquitin protein ligase binding p53 binding sumo transferase activity ubiquitin-protein transferase activity transferase activity ligase activity 5s rrna binding zinc ion binding ribonucleoprotein complex binding protein n-terminus binding ubiquitin protein ligase activity nedd8 ligase activity disordered domain specific binding protein domain specific binding receptor serine/threonine kinase binding peroxisome proliferator activated receptor binding ubiquitin binding cellular component cytosol endocytic vesicle membrane plasma membrane synapse nuclear body cytoplasm nucleus nucleoplasm nucleolus protein-containing complex biological process negative regulation of signal transduction by p53 class mediator endocardial cushion morphogenesis cellular response to uv-c atrial septum development regulation of heart rate dna damage response, signal transduction by p53 class mediator resulting in cell cycle arrest positive regulation of gene expression blood vessel development positive regulation of cell population proliferation negative regulation of dna damage response, signal transduction by p53 class mediator response to ether blood vessel remodeling cellular response to hypoxia heart valve development cellular response to estrogen stimulus negative regulation of apoptotic process cellular response to organic substance cellular response to hydrogen peroxide response to cocaine cardiac septum morphogenesis negative regulation of transcription by rna polymerase ii peptidyl-lysine modification positive regulation of cell cycle ventricular septum development positive regulation of protein export from nucleus response to steroid hormone cellular response to growth factor stimulus regulation of protein catabolic process cellular response to antibiotic negative regulation of gene expression positive regulation of mitotic cell cycle heart development cellular response to alkaloid cellular response to vitamin b1 response to magnesium ion negative regulation of cysteine-type endopeptidase activity involved in apoptotic process positive regulation of proteasomal ubiquitin-dependent protein catabolic process cellular response to peptide hormone stimulus cellular response to organic cyclic compound viral process response to iron ion regulation of gene expression response to antibiotic traversing start control point of mitotic cell cycle protein ubiquitination negative regulation of protein processing establishment of protein localization response to toxic substance response to morphine atrioventricular valve morphogenesis protein localization to nucleus regulation of signal transduction by p53 class mediator positive regulation of vascular associated smooth muscle cell proliferation response to water-immersion restraint stress negative regulation of neuron projection development positive regulation of vascular associated smooth muscle cell migration protein deubiquitination protein sumoylation transcription factor catabolic process protein autoubiquitination response to formaldehyde protein destabilization negative regulation of transcription, dna-templated proteolysis involved in cellular protein catabolic process cellular response to gamma radiation cellular response to actinomycin d negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator amyloid fibril formation protein-containing complex assembly ubiquitin-dependent protein catabolic process sources:amigo / quickgoorthologsspecieshumanmouseentrez419317246ensemblensg00000135679ensmusg00000020184uniprotq00987p23804refseq (mrna)nm_001145336nm_001145337nm_001145339nm_001145340nm_001278462nm_002392nm_006878nm_006879nm_006880nm_006881nm_006882nm_032739nm_001367990nm_001288586nm_010786refseq (protein)np_001138809np_001138811np_001138812np_001265391np_002383np_001354919np_001275515np_034916location (ucsc)chr 12: 68.81 – 68.85 mbchr 10: 117.52 – 117.55 mbpubmed searchwikidataview/edit humanview/edit mouse discovery and expression in tumor cells the murine double minute (mdm2) oncogene, which codes for the mdm2 protein, was originally cloned, along with two other genes (mdm1 and mdm3) from the transformed mouse cell line 3t3-dm. mdm2 overexpression, in cooperation with oncogenic ras, promotes transformation of primary rodent fibroblasts, and mdm2 expression led to tumor formation in nude mice. the human homologue of this protein was later identified and is sometimes called hdm2. further supporting the role of mdm2 as an oncogene, several human tumor types have been shown to have increased levels of mdm2, including soft tissue sarcomas and osteosarcomas as well as breast tumors. the mdm2 oncoprotein ubiquitinates and antagonizes p53 but may also carry out p53-independent functions. mdm2 supports the polycomb-mediated repression of lineage-specific genes, independent of p53. mdm2 depletion in the absence of p53 promoted the differentiation of human mesenchymal stem cells and diminished clonogenic survival of cancer cells. most of the mdm2-controlled genes also responded to the inactivation of the polycomb repressor complex 2 (prc2) and its catalytic component ezh2. mdm2 physically associated with ezh2 on chromatin, enhancing the trimethylation of histone 3 at lysine 27 (h3k27me3) and the ubiquitination of histone 2a at lysine 119 (h2ak119) at its target genes. removing mdm2 simultaneously with the h2ak119 e3 ligase ring1b/rnf2 further induced these genes and synthetically arrested cell proliferation. an additional mdm2 family member, mdm4 (also called mdmx), has been discovered and is also an important negative regulator of p53. mdm2 is also required for organ development and tissue homeostasis because unopposed p53 activation leads to p53-overactivation-dependent cell death, referred to as podoptosis. podoptosis is caspase-independent and, therefore, different from apoptosis. the mitogenic role of mdm2 is also needed for wound healing upon tissue injury, while mdm2 inhibition impairs re-epithelialization upon epithelial damage. in addition, mdm2 has p53-independent transcription factor-like effects in nuclear factor-kappa beta (nfκb) activation. therefore, mdm2 promotes tissue inflammation and mdm2 inhibition has potent anti-inflammatory effects in tissue injury. so, mdm2 blockade had mostly anti-inflammatory and anti-mitotic effects that can be of additive therapeutic efficacy in inflammatory and hyperproliferative disorders such as certain cancers or lymphoproliferative autoimmunity, such as systemic lupus erythematosus or crescentic glomerulonephritis. ubiquitination target: p53 the key target of mdm2 is the p53 tumor suppressor. mdm2 has been identified as a p53 interacting protein that represses p53 transcriptional activity. mdm2 achieves this repression by binding to and blocking the n-terminal trans-activation domain of p53. mdm2 is a p53 responsive gene—that is, its transcription can be activated by p53. thus when p53 is stabilized, the transcription of mdm2 is also induced, resulting in higher mdm2 protein levels. e3 ligase activity the e3 ubiquitin ligase mdm2 is a negative regulator of the p53 tumor suppressor protein. mdm2 binds and ubiquitinates p53, facilitating it for degradation. p53 can induce transcription of mdm2, generating a negative feedback loop. mdm2 also acts as an e3 ubiquitin ligase, targeting both itself and p53 for degradation by the proteasome (see also ubiquitin). several lysine residues in p53 c-terminus have been identified as the sites of ubiquitination, and it has been shown that p53 protein levels are downregulated by mdm2 in a proteasome-dependent manner. mdm2 is capable of auto-polyubiquitination, and in complex with p300, a cooperating e3 ubiquitin ligase, is capable of polyubiquitinating p53. in this manner, mdm2 and p53 are the members of a negative feedback control loop that keeps the level of p53 low in the absence of p53-stabilizing signals. this loop can be interfered with by kinases and genes like p14arf when p53 activation signals, including dna damage, are high. structure and function the full-length transcript of the mdm2 gene encodes a protein of 491 amino acids with a predicted molecular weight of 56kda. this protein contains several conserved structural domains including an n-terminal p53 interaction domain, the structure of which has been solved using x-ray crystallography. the mdm2 protein also contains a central acidic domain (residues 230-300). the phosphorylation of residues within this domain appears to be important for regulation of mdm2 function. in addition, this region contains nuclear export and import signals that are essential for proper nuclear-cytoplasmic trafficking of mdm2. another conserved domain within the mdm2 protein is a zinc finger domain, the function of which is poorly understood. mdm2 also contains a c-terminal ring domain (amino acid residues 430-480), which contains a cis3-his2-cis3 consensus that coordinates two ions of zinc. these residues are required for zinc binding, which is essential for proper folding of the ring domain. the ring domain of mdm2 confers e3 ubiquitin ligase activity and is sufficient for e3 ligase activity in mdm2 ring autoubiquitination. the ring domain of mdm2 is unique in that it incorporates a conserved walker a or p-loop motif characteristic of nucleotide binding proteins, as well as a nucleolar localization sequence. the ring domain also binds specifically to rna, although the function of this is poorly understood. regulation there are several known mechanisms for regulation of mdm2. one of these mechanisms is phosphorylation of the mdm2 protein. mdm2 is phosphorylated at multiple sites in cells. following dna damage, phosphorylation of mdm2 leads to changes in protein function and stabilization of p53. additionally, phosphorylation at certain residues within the central acidic domain of mdm2 may stimulate its ability to target p53 for degradation. hipk2 is a protein that regulates mdm2 in this way. the induction of the p14arf protein, the alternate reading frame product of the p16ink4a locus, is also a mechanism of negatively regulating the p53-mdm2 interaction. p14arf directly interacts with mdm2 and leads to up-regulation of p53 transcriptional response. arf sequesters mdm2 in the nucleolus, resulting in inhibition of nuclear export and activation of p53, since nuclear export is essential for proper p53 degradation. inhibitors of the mdm2-p53 interaction include the cis-imidazoline analog nutlin. levels and stability of mdm2 are also modulated by ubiquitylation. mdm2 auto ubiquitylates itself, which allows for its degradation by the proteasome. mdm2 also interacts with a ubiquitin specific protease, usp7, which can reverse mdm2-ubiquitylation and prevent it from being degraded by the proteasome. usp7 also protects from degradation the p53 protein, which is a major target of mdm2. thus mdm2 and usp7 form an intricate circuit to finely regulate the stability and activity of p53, whose levels are critical for its function. interactions overview of signal transduction pathways involved in apoptosis. mdm2 has been shown to interact with: abl1, arrb1, arrb2, ccng1, ctbp1, ctbp2, daxx, dhfr, ep300, erich3, fkbp3, foxo4, gnl3, hdac1, hif1a, htatip, igf1r, mdm4, numb, p16, p53, p73, pcaf, psmd10, psme3, rpl5, rpl11, pml, rpl26, rrm2b, rybp, tbp, and ubc. mdm2 p53-independent role mdm2 overexpression was shown to inhibit dna double-strand break repair mediated through a novel, direct interaction between mdm2 and nbs1 and independent of p53. regardless of p53 status, increased levels of mdm2, but not mdm2 lacking its nbs1-binding domain, caused delays in dna break repair, chromosomal abnormalities, and genome instability. these data demonstrated mdm2-induced genome instability can be mediated through mdm2:nbs1 interactions and independent from its association with p53.